Cell Based Assays Market to Grow with a CAGR of 8.30% through 2030
Increasing number of drug discoveries is expected to
drive the growth of global Cell Based Assays in the forecast period, 2026-2030.
According to TechSci Research report, “Cell Based
Assays Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2030F”, the Global Cell Based Assays Market was valued at
USD 17.28 Billion in 2024 and is expected to reach USD 27.88 Billion by 2030
with a CAGR of 8.30%. This can be ascribed to the increasing demand
for identification and optimization procedures in drug development along with
the rapid adoption of cell-based assays by biopharmaceutical companies across
the globe. Additionally, technological advancements in the end users for
cell-based assays and introduction of new drugs especially in the developed
countries in the North America and Europe, altogether, are expected to create
lucrative opportunities for the market growth in the coming years. Besides, increasing
investment for research and demand for manufacturing of cell-based assay
products in underdeveloped and developing countries are further expected to
support the market growth. Similarly, in biomedical research screening for
biological activity and biochemical mechanisms, and off-target interactions for
a molecule is anticipated to boost the market growth during the forecasted
year. Also, many private firms offer customized assays that suit individual
research need a focus on a therapeutic regime to combat a particular disease
which will further drive the market growth during the forecasted years.
However, increasing usage of expensive systems and high
price of the instruments often reduce the return on investment, thereby
creating low adoption, consequently, slowing down the growth of
global cell-based assays market in the forecast period. Similarly, a
dearth of suitable professionals may hamper the cell-based
assays market growth during the forecast period. Also, the lack of
awareness about new assays for the research and development in emerging
countries can further restrict the growth of global cell-based
assays market.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Cell Based Assays Market"
The global Cell Based Assays Market is segmented into
products and services, application, end user, regional distribution, and
company.
Based on Application, the Drug Discovery & Development segment is
experiencing the fastest growth in the global Cell-Based Assays Market. This
surge is fueled by escalating demand for innovative therapeutics, increasing
R&D investments, and the adoption of advanced technologies that enhance the
efficiency and predictive power of drug screening processes. Cell-based assays
are integral to modern drug discovery workflows, providing physiologically
relevant models that enable researchers to assess the efficacy and toxicity of
potential drug candidates early in the development process. Their ability to
mimic human cellular responses more accurately than traditional methods reduces
reliance on animal testing and improves the translational success of preclinical
studies. The growing prevalence of chronic diseases, such as cancer,
cardiovascular disorders, and neurodegenerative conditions, has intensified the
need for effective drug discovery strategies. Governments and health
organizations are responding by increasing funding and support for research
initiatives.
Based on the Region, Asia Pacific is witnessing the fastest
growth in the global Cell Based Assays Market, driven by expanding
biotechnology sectors, growing pharmaceutical R&D investments, and
increasing government support for healthcare infrastructure modernization. The
region’s rapid economic development, particularly in countries like China,
India, Japan, and South Korea, is fostering a strong foundation for
biotechnological innovations and clinical research. Governments across Asia
Pacific are actively promoting biotechnology as a strategic sector. For
instance, the Indian government’s Department of Biotechnology (DBT) has
launched initiatives like the Biotechnology Industry Research Assistance
Council (BIRAC) to support startups and researchers working on cell-based
technologies. Similarly, China’s “Made in China 2025” initiative emphasizes
biopharmaceutical development, including the use of cell-based assays for drug
screening and toxicity testing. In addition to public investments, the region
benefits from a growing number of contract research organizations (CROs) that
are increasingly adopting cell-based assays for drug development services. This
is fueled by the relatively lower cost of conducting clinical and preclinical
studies in Asia compared to Western countries. The demand for targeted and
personalized medicine is also growing in Asia Pacific, encouraging the use of
advanced cell-based models like 3D cultures and organ-on-a-chip systems.
Major companies operating in Global Cell-Based Assays
Market are:
- Corning,
Inc.
- Bio-Rad
Laboratories, Inc.
- Thermo
Fisher Scientific Inc.
- Danaher
Corporation
- Lonza
Group AG
- Promega
Corporation
- F.
Hoffmann-La Roche AG
- Merck
KGaA
- Charles
River Laboratories International, Inc.
- Menarini
Silicon Biosystems, Inc.
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“North America was expected to dominate in the Global Cell
Based Assays market due to the increasing research and development
activities in different research institutes collaboratively sponsored by
academic grants and biopharmaceutical grants across the region. Similarly, the
growing prevalence of lifestyle disorders such as arthritis, diabetes,
epilepsy, cancer, cardiovascular diseases, and others is expected to drive the
growth of the market during the forecast period. Also, growing demand for drug
testing such as toxicity studies, drug screening, in vitro screening, in vitro
testing and others are also a major factor fueling the growth of the market.
Furthermore, increasing development of healthcare expenditure and growing
favorable reimbursement policies for the different diseases treatment are
further contributing to the demand for cell-based assays. Besides, increasing
investment by government organizations for development of new cell-based assays
in the region is further expected to create lucrative opportunities for the
market growth”, said Mr. Karan Chechi, Research Director of TechSci Research, a
research based global management consulting firm.
“Cell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Products & Services (Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others), By Application (Clinical Research, Drug Discovery & Development, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations), By Region and Competition, 2020-2030F”, has evaluated the future growth
potential of global cell-based assays market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global cell-based assays market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com